Summary. In mice, neither the bleeding time nor the clotting time of whole blood was different on Day 2 of pregnancy compared with pseudopregnancy. Standardization of the platelet concentration to 106/\g=m\lplasma resulted in a significant reduction in the clotting time of plasma from pregnant animals. This reduction was not due to an increase in the intrinsic or extrinsic pathways of the coagulation cascade but to enhanced platelet factor III activity, indicating increased platelet activation and consumption. Increased activation was not due to immunological recognition of the embryo because thrombocytopenia occurred after syngeneic and allogeneic matings of inbred strains of mice and also after parthenogenetic activation of ova in situ. Injection of embryo culture medium into splenectomized mice induced a significant dose\x=req-\ dependent thrombocytopenia. It occurred within 10 min after injection and persisted for up to 2 h. There was no reduction in platelet count when animals were injected with culture media in which unfertilized ova had been incubated. Early pregnancy\x=req-\ associated thrombocytopenia was caused by the production of platelet-activating factors by the fertilized eggs. The induction of thrombocytopenia by embryo culture media displayed a dose\p=n-\response curve that was parallel to that of the pl atel et\x=req-\ activating factor, 1-0-alkyl-2-acetyl-sn-glycero(3)phosphocholine.
Introduction
Thrombocytopenia has been shown to be an initial maternal response to conception (O'Neill, 1985) . A significant reduction in blood platelet numbers occurred within 6 h of fertilization and was maintained for the first week of pregnancy. This response was dependent upon the presence of fertilized eggs, and the extent of thrombocytopenia was directly correlated with the number of zygotes in the reproductive tract (O'Neill, 1985) . This paper examines whether thrombocytopenia in early pregnancy in mice was: (1) due to intravascular coagulation in early pregnancy; (2) a consequence of immunological responses against the genetically foreign embryo; or (3) due to production of platelet-activating factors by the fertilized ovum.
Blood platelets have a central role in both coagulation and immune reactions (Willis, 1978) and thrombocytopenia most commonly accompanies conditions such as immunological reactions and intravascular coagulation. Platelet activation and thrombocytopenia have been implicated in graft rejection (Lowenhaupt & Nathan, 1969) , reaction to bacteria and viruses (Copley, 1978) , the albeit at low levels (Muggleton-Harris & Johnson, 1976; Heyner, Hunziker & Zink, 1980;  Epstein, Smith & Travis, 1980; Savicki, Magnuson & Epstein, 1981) .
The role of blood platelets as mediators and promoters of blood coagulation is well defined (Holmsen, Salganicoff & Fukami, 1977) . In vivo, platelet activation may either initiate, or be caused by, the coagulation cascade. The end result in both cases is the consumption of platelets.
To determine whether platelet-activating factors are produced by the zygote the effect of embryo culture medium upon the peripheral blood platelet count of splenectomized mice was determined and compared with the effects of activators of the three main pathways of platelet activation (Haslam, 1964) .
Materials and Methods
Female mice of the Quackenbush, CBA/J or C57BL/6 strains were exposed to light from 07:30 h to 21:30 h daily. Females at 10 weeks of age were placed with fertile or vasectomized males and checked each morning for the presence of vaginal plugs (Day 1).
Mice were bled from the periorbital plexus under light ether anaesthesia and platelet counts were performed as described by O'Neill (1985) . Briefly, 200 µ blood were mixed with EDTA anti¬ coagulant and 10 µ of this blood were diluted 1:200 with 1% (w/v) ammonium oxalate. The plate¬ lets were counted using a Neubauer haemocytometer and phase-contrast microscopy. (Staats, 1972) . Females aged 10 weeks were mated with 3-6-month-old-males.
Females were removed on the day that a vaginal plug was observed. Platelet counts were performed before mating and at 16:00 h on Day 2 of pregnancy.
Parthenogenesis. Females of the Quackenbush strain, 10 weeks of age, were induced to ovulate by an injection of 5 i.u. PMSG (Folligon: Intervet, Boxmeer, The Netherlands) and 5 i.u. hCG (Chorulon: Intervet). After 12 h, parthenogenesis was induced by anaesthetizing animals with 2,2,2-tribromoethanol (Fluka AG, Switzerland), freshly prepared as a 1-2% (w/v) solution in 0154 M-NaCl and given at a dose of 0-02 ml/g body weight (Kaufman, 1978) . Such treatment has been shown to induce parthenogenetic activation of ova in about 20% of treated females (Kaufman, 1978) .
Animals were autopsied 24 h later to determine whether parthenogenesis had occurred. The oviducts were flushed with Dulbecco's phosphate buffered saline (PBS) (pH 7-4) (8-0 g NaCl, 0-2 g KC1, 115 g Na2HP04, 0-2 g KH2P04, 0-1 g CaCl2, 0-1 g MgCl2.6H20/l). The same procedure was carried out using platelet-rich plasma and platelet-poor plasma from pregnant and pseudopregnant mice. The platelet-rich plasma was standardized to a concentration of 106 platelets/µ .
Platelet factor III. Platelet-rich plasma was collected and the platelet concentration adjusted to 106/µ1 :100 samples were incubated with 100 µ imidazole-buffered saline (pH 7-4) containing 5 mg kaolin/ml (Ajax Chemicals, Sydney, Australia). The samples were incubated at 37°C for 0, 20, 40 and 60 min. The extent of kaolin-induced release of platelet factor III was tested by measuring the clotting time after recalcification (Roper-Drewinko et ai, 1981) .
Activated partial thromboplastin time. The intrinsic clotting pathway was studied by mixing 100 µ platelet-poor plasma with 100 µ reconstituted rabbit brain extract (partial thromboplastin) and the solid activator, celite (Cephalite: bioMerieux, Charbonierres Les Bains, France). This was incubated at 37°C for exactly 3 min. Prewarmed calcium chloride (100 µ , 25 mM) was added, and the clotting time recorded (Proctor & Rapaport, 1961) .
Prothrombin (complete thromboplastin) time. The extrinsic coagulation pathway was examined by adding 100 µ prewarmed, complete thromboplastin containing excess calcium (thromboplastin with calcium ; bioMerieux, France) to 100 µ prewarmed platelet-poor plasma. The thromboplastin was used as 1:2, 1:4 and 1:8 dilutions in Michaelis buffer (bioMerieux, France), and the clotting time was recorded (Quick, 1935 (Haslam, 1964) were tested to determine whether they displayed a profile of activation in vivo similar to that caused by embryo culture medium.
Adenosine-5'-diphosphate (sodium salt.2H20: Calbiochem-Behring, Aust. Pty Ltd, Sydney, Australia) was prepared at a concentration of 5mg/ml in PBS and, after dilution, doses of 10, 0-25 or 006 mg in 200 µ PBS were injected into splenectomized mice. Arachidonic acid (porcine liver: Calbiochem-Behring) was dissolved in chloroform and then made up in PBS. Splenectomized mice were given doses of 0-5, 01 or 0-05 mg in 200 µ . Synthetic platelet-activating factor (PAF-acether) (Calbiochem-Behring), 1 mg, was resuspended in 1 ml chloroform-methanol (2:1 v/v) and was then diluted in PBS containing 0-25% bovine serum albumin (PBS-BSA). Various volumes of this preparation were tested in the bioassay.
Results

Experiment 1
Significant thrombocytopenia resulted from the syngeneic and allogeneic matings (Table 1 ). The extent of thrombocytopenia was similar in all crosses performed.
The blood platelet count (mean ± s.e.m.) after parthenogenetic activation of ova (1086 ± 84 103/µ1, 5 replicates) was significantly lower (P < 0-01) than in those mice given gonadotrophins without anaesthesia (1695 + 154 103/µ1,4 replicates), and in those in which parthenogenesis did not occur after administration of tribromoethanol (1612 ± 125 x 103/µ1, 7 replicates). 
Experiment 3
Culture media in which 8-16-cell embryos grew for 24 h contained factor(s) which caused significant thrombocytopenia in splenectomized mice. This effect was dose-dependent, showing a maximum response after injection of at least 300 µ culture medium (Text-fig. 3 ). The reaction occurred within 5 min and reached a maximum at 10 min, persisting for up to 120 min (Text- fig. 4 ). There was no reduction in platelet concentration after injection of media from cultures of unfertilized ova. The elevation in platelet numbers in control animals was probably due to the reduction in plasma volume that was observed after injection (Text- fig. 4 ). This change in haematocrit occurred after injection of control and embryo culture media. These changes in plasma volume were not taken into account when calculating the change in platelet count. Using the splenectomized mouse bioassay, neither adenosine diphosphate nor arachidonic acid had platelet-activating effects at any dose tested. Intraperitoneal injection of small doses of 1-0-alkyl-2-acetyl-sw-glycero(3)phosphocholine caused a significant thrombocytopenia in splenecto¬ mized mice (Text- fig. 5 ). It also showed a parallel dose-response curve and the same temporal profile of onset of thrombocytopenia to that induced by embryo culture medium (Text- fig. 6 ). (Krco & Goldberg, 1976; Epstein et ai, 1980) . Thus, even in sygeneic matings, these embryos could provide an immunological target. To overcome this objection, the platelet count was performed on females with parthenogenetically activated ova. Such embryos develop normally throughout the preimplantation stage of pregnancy, but do not provide immunological targets. Despite this, significant thrombocytopenia occurred 24 h after partheno¬ genetic activation of ova. This was not due to an effect on the platelet count by the gonadotrophins or the anaesthetic.
It is possible that there may be immunological recognition of embryo-specific antigens expressed by the preimplantation embryo (Shevinsky, Knowles, Damjanov & Solter, 1982) but a direct test is difficult. However, the very rapid onset of thrombocytopenia (O'Neill, 1985) and the demonstration of production of platelet-activating factor(s) by the embryo suggests that this is unlikely to be the case.
The reduction in platelet count after mating of inbred strains of mice was not as great as in Quackenbush strain mice. The reason for this diminished response is probably due to the fact that CBA/J and C57BL/6 mice produced fewer embryos (7-7 and 7-2 implantation sites, respectively (Harlow, 1980) ) than did Quackenbush strain mice (14-4 implantation sites, results not shown). O'Neill (1985) showed that the degree of thrombocytopenia was correlated with the number of embryos present in the reproductive tract.
Platelets are activated by a vast range of factors (review by Holmsen et ai, 1977 (Harker & Slichter, 1972) . Since there was a reduction in the platelet concentration during early pregnancy (O'Neill, 1985) an increase in the bleeding and clotting times were similar for pregnant and pseudopregnant mice ( Table 2 ). The activity of the intrinsic (Table 2) and extrinsic (Text- fig. 1 ) pathways of coagulation did not increase during early pregnancy and could not, therefore, explain the maintenance of normal bleeding times in the presence of thrombocytopenia.
When the platelet concentration of plasma from pregnant and pseudopregnant mice was standardized to 106/µ1, a reduction occurred in clotting time of blood from pregnant mice (Table 2) . Platelets exert a major effect on blood clotting by the release of platelet factor III. The release of this factor was enhanced on Day 2 of pregnancy (Text- fig. 2 ). This increased availability of platelet factor III during early pregnancy explains why normal bleeding times were maintained even when the platelet concentration was reduced. Increased platelet factor III activity was also likely to be the reason for the reduced clotting time of platelet-poor plasma from Day-2 pregnant mice (Table 2) . Platelet factor III is released after activation of platelets. If the thrombocytopenia associated with early pregnancy was simply due to platelet destruction, for instance by the reticuloendothelial system, then platelet factor III activity would not occur (Hardisty & Hutton, 1966 (O'Neill, 1985) . The removal of this reservoir means that any change in the total platelet population is reflected as a change in the peripheral blood platelet count. The ADP and arachidonic acid pathways of platelet activation had little effect in this assay while PAF-acether had very potent platelet-activating effects (Text- fig. 5 ). The failure of ADP and arachidonic acid to cause thrombocytopenia was probably due to degradation of these reagents before they could have significant effects on platelets in circulation. Intravenous administration of these promoters may have resulted in more profound effects. This experiment was not necessary, however, since the active factor in embryo culture medium exerted its effects after intraperitoneal injection. PAF-acether had a temporal profile of induction of thrombocytopenia that was similar to and a dose-response curve that was parallel to that caused by embryo culture medium . This suggests that the active factor(s) may have been the same or were exerting their effects via the same pathway as PAF-acether. Fishel & Surani (1980) described the production of a high molecular weight glycoprotein by the preimplantation mouse embryo but a biological function for this factor was not described. Cavanagh, Morton, Rolfe & Gidley-Baird (1980) described a low molecular weight factor produced by the zygote which acted in concert with factors from the oviduct and ovary to exert, as yet, illdefined effects on maternal lymphocytes. There have been no previous reports of the production by the preimplantation mammalian embryo of factor(s) with the potent physiological effects described here. It will be important to characterize biochemically the factor produced by embryos to determine whether it is homologous to the platelet-activating factor, l-O-alkyl-2-acetyl-snglycero(3)phosphocholine. PAF-acether was first discovered by the observation that leucocytes, sensitized with specific IgE antibody and challenged with antigen in vitro, released a potent substance which caused platelet activation (Benveniste, Henson & Cochrane, 1972) . It was produced by basophils (Benveniste, 1974) , neutrophils (Lotner, Lynch, Betz & Henson, 1980) , macrophages (Ninio, Benveniste, 1979) and the renal medulla (Blank, Snyder, Byers, Brooks & Muirhead, 1979) . The wide diversity of cell types which produce PAF-acether, its relatively simple biosynthetic pathway (Polonsky et ai, 1980; Ninio et ai, 1982) and its potency at low concentrations (Camussi, Tetta & Bussolino, 1983) make it an attractive candidate for an early embryonic message.
The effect of platelet activation and thrombocytopenia induced by embryo-derived factors on the outcome of pregnancy is yet to be defined. The discovery of an embryo-derived platelet activating factor and its detection by a simple bioassay suggests that it may be possible to use this factor: (1) as a quantifiable and non-invasive means of assessing the viability of embryos in vitro; (2) as a method of quality control of embryo culture procedures; and (3) to allow the survival of embryos to be monitored in utero.
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